Literature DB >> 15231996

Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release.

Nadia De Mota1, Annabelle Reaux-Le Goazigo, Said El Messari, Nicolas Chartrel, Darren Roesch, Cynthia Dujardin, Claude Kordon, Hubert Vaudry, Françoise Moos, Catherine Llorens-Cortes.   

Abstract

Apelin, a recently isolated neuropeptide that is expressed in the supraoptic and the paraventricular nuclei, acts on specific receptors located on vasopressinergic neurons. The increased phasic pattern of these neurons facilitates sustained antidiuresis during dehydration or lactation. Here, we investigated whether apelin interacts with arginine vasopressin (AVP) to maintain body fluid homeostasis. We first characterized the predominant molecular forms of endogenous hypothalamic and plasma apelin as corresponding to apelin 13 and, to a lesser extent, to apelin 17. We then demonstrated that, in lactating rats, apelin was colocalized with AVP in supraoptic nucleus magnocellular neurons and given intracerebroventricularly inhibited the phasic electrical activity of AVP neurons. In lactating mice, intracerebroventricular administration of apelin 17 reduced plasma AVP levels and increased diuresis. Moreover, water deprivation, which increases systemic AVP release and causes depletion of hypothalamic AVP stores, decreased plasma apelin concentrations and induced hypothalamic accumulation of the peptide, indicating that AVP and apelin are conversely regulated to facilitate systemic AVP release and suppress diuresis. Opposite effects of AVP and apelin are likely to occur at the hypothalamic level through autocrine modulation of the phasic electrical activity of AVP neurons. Altogether, these data demonstrate that apelin acts as a potent diuretic neuropeptide counteracting AVP actions through inhibition of AVP neuron activity and AVP release. The coexistence of apelin and AVP in magnocellular neurons, their opposite biological effects, and regulation are likely to play a key role for maintaining body fluid homeostasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231996      PMCID: PMC478592          DOI: 10.1073/pnas.0403518101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Electrophysiological differentiation of oxytocin- and vasopressin-secreting neurones.

Authors:  D A Poulain; J B Wakerley; R E Dyball
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-04

2.  Differential routing of coexisting neuropeptides in vasopressin neurons.

Authors:  Marc Landry; Evelyne Vila-Porcile; Tomas Hökfelt; André Calas
Journal:  Eur J Neurosci       Date:  2003-02       Impact factor: 3.386

3.  Synthesis, transport, and release of posterior pituitary hormones.

Authors:  M J Brownstein; J T Russell; H Gainer
Journal:  Science       Date:  1980-01-25       Impact factor: 47.728

4.  Immunohistochemical localization and radioimmunoassay of corticotropin-releasing factor in the forebrain and hypophysis of the frog Rana ridibunda.

Authors:  M C Tonon; A Burlet; M Lauber; P Cuet; S Jégou; L Gouteux; N Ling; H Vaudry
Journal:  Neuroendocrinology       Date:  1985-02       Impact factor: 4.914

5.  Relative efficiency of neural firing patterns for vasopressin release in vitro.

Authors:  R J Bicknell; G Leng
Journal:  Neuroendocrinology       Date:  1981-11       Impact factor: 4.914

6.  Aminopeptidase A inhibitors as potential central antihypertensive agents.

Authors:  A Reaux; M C Fournie-Zaluski; C David; S Zini; B P Roques; P Corvol; C Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

7.  Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor, APJ.

Authors:  Naiming Zhou; Xuejun Fan; Muhammad Mukhtar; Jianhua Fang; Charvi A Patel; Garrett C DuBois; Roger J Pomerantz
Journal:  Virology       Date:  2003-03-01       Impact factor: 3.616

8.  Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.

Authors:  Andrew D Medhurst; Carol A Jennings; Melanie J Robbins; Robert P Davis; Catherine Ellis; Kim Y Winborn; Kenneth W M Lawrie; Guillaume Hervieu; Graham Riley; Jane E Bolaky; Nicole C Herrity; Paul Murdock; John G Darker
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

9.  Phasic firing enhances vasopressin release from the rat neurohypophysis.

Authors:  A Dutton; R E Dyball
Journal:  J Physiol       Date:  1979-05       Impact factor: 5.182

10.  Distribution of apelin-synthesizing neurons in the adult rat brain.

Authors:  A Reaux; K Gallatz; M Palkovits; C Llorens-Cortes
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

View more
  88 in total

1.  A novel osmosensitive voltage gated cation current in rat supraoptic neurones.

Authors:  Xiao-Hong Liu; Wenbo Zhang; Thomas E Fisher
Journal:  J Physiol       Date:  2005-08-11       Impact factor: 5.182

Review 2.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

3.  Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli.

Authors:  Michel Azizi; Xavier Iturrioz; Anne Blanchard; Séverine Peyrard; Nadia De Mota; Nicolas Chartrel; Hubert Vaudry; Pierre Corvol; Catherine Llorens-Cortes
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

4.  Pressor effect of apelin-13 in the rostral ventrolateral medulla: role of NAD(P)H oxidase-derived superoxide.

Authors:  Fanrong Yao; Amit Modgil; Qi Zhang; Ajeeth Pingili; Neha Singh; Stephen T O'Rourke; Chengwen Sun
Journal:  J Pharmacol Exp Ther       Date:  2010-11-03       Impact factor: 4.030

Review 5.  Multiple signalling modalities mediated by dendritic exocytosis of oxytocin and vasopressin.

Authors:  Mike Ludwig; Javier Stern
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

6.  Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin.

Authors:  Sophie Le Gonidec; Carline Chaves-Almagro; Yushi Bai; Hye Jin Kang; Allyson Smith; Estelle Wanecq; Xi-Ping Huang; Hervé Prats; Bernard Knibiehler; Bryan L Roth; Larry S Barak; Marc G Caron; Philippe Valet; Yves Audigier; Bernard Masri
Journal:  FASEB J       Date:  2017-02-27       Impact factor: 5.191

7.  Apelin: a novel marker for the patients with first ST-elevation myocardial infarction.

Authors:  Agnieszka M Kuklinska; Bozena Sobkowicz; Robert Sawicki; Wlodzimierz J Musial; Ewa Waszkiewicz; Swietlana Bolinska; Jolanta Małyszko
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

8.  By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization.

Authors:  Xavier Iturrioz; Romain Gerbier; Vincent Leroux; Rodrigo Alvear-Perez; Bernard Maigret; Catherine Llorens-Cortes
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

9.  Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis.

Authors:  Hiroyasu Kidoya; Masaya Ueno; Yoshihiro Yamada; Naoki Mochizuki; Mitsugu Nakata; Takashi Yano; Ryo Fujii; Nobuyuki Takakura
Journal:  EMBO J       Date:  2008-01-17       Impact factor: 11.598

10.  Abnormal fluid homeostasis in apelin receptor knockout mice.

Authors:  Emma M Roberts; Michael J F Newson; George R Pope; Rainer Landgraf; Stephen J Lolait; Anne-Marie O'Carroll
Journal:  J Endocrinol       Date:  2009-07-03       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.